Chemoproteomic and Transcriptomic Analysis Reveals that O-GlcNAc Regulates Mouse Embryonic Stem Cell Fate through the Pluripotency Network

© 2023 Wiley-VCH GmbH..

Self-renewal and differentiation of embryonic stem cells (ESCs) are influenced by protein O-linked β-N-acetylglucosamine (O-GlcNAc) modification, but the underlying mechanism remains incompletely understood. Herein, we report the identification of 979 O-GlcNAcylated proteins and 1340 modification sites in mouse ESCs (mESCs) by using a chemoproteomics method. In addition to OCT4 and SOX2, the third core pluripotency transcription factor (PTF) NANOG was found to be modified and functionally regulated by O-GlcNAc. Upon differentiation along the neuronal lineage, the O-GlcNAc stoichiometry at 123 sites of 83 proteins-several of which were PTFs-was found to decline. Transcriptomic profiling reveals 2456 differentially expressed genes responsive to OGT inhibition during differentiation, of which 901 are target genes of core PTFs. By acting on the core PTF network, suppression of O-GlcNAcylation upregulates neuron-related genes, thus contributing to mESC fate determination.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:62

Enthalten in:

Angewandte Chemie (International ed. in English) - 62(2023), 17 vom: 17. Apr., Seite e202300500

Sprache:

Englisch

Beteiligte Personen:

Hao, Yi [VerfasserIn]
Li, Xiang [VerfasserIn]
Qin, Ke [VerfasserIn]
Shi, Yujie [VerfasserIn]
He, Yanwen [VerfasserIn]
Zhang, Che [VerfasserIn]
Cheng, Bo [VerfasserIn]
Zhang, Xiwen [VerfasserIn]
Hu, Guangyu [VerfasserIn]
Liang, Shuyu [VerfasserIn]
Tang, Qi [VerfasserIn]
Chen, Xing [VerfasserIn]

Links:

Volltext

Themen:

Acetylglucosamine
Chemoproteomics
Embryonic Stem Cells
Journal Article
O-Linked β-N-Acetylglucosamine
Pluripotency Transcription Factors
Research Support, Non-U.S. Gov't
Transcriptomics
V956696549

Anmerkungen:

Date Completed 07.04.2023

Date Revised 17.04.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/anie.202300500

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM353585513